These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5610735)

  • 1. [Results obtained in the treatment of post-transfusional hemosiderosis with desferrioxamine ina case of hypoplastic congenital anemia of the Joseph-Blackfan-Diamon type].
    Nicolini A; Marca L; Pani C
    Minerva Pediatr; 1967 Aug; 19(34):1590-2. PubMed ID: 5610735
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
    Hildner FJ; Monto RW; Rebuck JW
    Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
    Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
    [No Abstract]   [Full Text] [Related]  

  • 5. Desferrioxamine and transfusional iron overload.
    Lancet; 1978 Mar; 1(8062):479-80. PubMed ID: 76025
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved pituitary gonadotrophin response in adult transfusional haemosiderosis following desferrioxamine treatment.
    Waters AK
    Horm Metab Res; 1982 Jan; 14(1):55. PubMed ID: 7061039
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A; Khalifa AS; Rahman YA; el-Bagoury I
    J Trop Med Hyg; 1969 Jan; 72(1):22-6. PubMed ID: 5773810
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis.
    Smeets ME; Vreugdenhil G; Holdrinet RS
    Am J Hematol; 1996 Mar; 51(3):243-4. PubMed ID: 8619408
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
    Kaung DT
    J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibilities and limitation of desferrioxamine treatment of transfusion hypersiderosis in children].
    Orsini A; Passeron P; Perrimond H; Pierron H
    Pediatrie; 1968; 23(5):588-9. PubMed ID: 5675452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
    Krüger N; Kijewski H; König R; Tillmann W; Schröter W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
    Fujiyama N; Nakazawa K
    Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of hemosiderosis with deferoxamine].
    Strohmeyer G; Stremmel W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1669-70. PubMed ID: 6489179
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hemodialysis hemosiderosis with desferrioxamine.
    Rembold CM; Krumlovsky FA; Roxe DM; Fitzsimmons E; del Greco F
    Trans Am Soc Artif Intern Organs; 1982; 28():621-6. PubMed ID: 7164314
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
    Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
    Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
    Vadász G
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2077-80. PubMed ID: 4216814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and metabolic research on treatment with desferrioxamine B in various hemosiderotic erythrocyte diseases].
    Cimino R; Quattrin N
    Clin Ter; 1965 Jul; 34(1):3-32. PubMed ID: 5840761
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
    Tillmann W; König R; Schröder K; Schröter W
    Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of continuous subcutaneous infusion of deferoxamine in a boy with congenital hypoplastic anemia].
    Ishitoya N; Gomibuchi I; Fujisawa K; Akatsuka J
    Rinsho Ketsueki; 1988 Sep; 29(9):1408-12. PubMed ID: 3216512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.